227 related articles for article (PubMed ID: 37076591)
1. Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation.
Messelodi D; Strocchi S; Bertuccio SN; Baden P; Indio V; Giorgi FM; Taddia A; Serravalle S; Valente S; di Fonzo A; Frattini E; Bernardoni R; Pession A; Grifoni D; Deleidi M; Astolfi A; Pession A
Commun Biol; 2023 Apr; 6(1):431. PubMed ID: 37076591
[TBL] [Abstract][Full Text] [Related]
2. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin.
Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L
J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774
[TBL] [Abstract][Full Text] [Related]
3. Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease.
Jackson KL; Viel C; Clarke J; Bu J; Chan M; Wang B; Shihabuddin LS; Sardi SP
Neurobiol Dis; 2019 Oct; 130():104513. PubMed ID: 31233883
[TBL] [Abstract][Full Text] [Related]
4. Viable neuronopathic Gaucher disease model in Medaka (Oryzias latipes) displays axonal accumulation of alpha-synuclein.
Uemura N; Koike M; Ansai S; Kinoshita M; Ishikawa-Fujiwara T; Matsui H; Naruse K; Sakamoto N; Uchiyama Y; Todo T; Takeda S; Yamakado H; Takahashi R
PLoS Genet; 2015 Apr; 11(4):e1005065. PubMed ID: 25835295
[TBL] [Abstract][Full Text] [Related]
5. c-Abl activates RIPK3 signaling in Gaucher disease.
Yañez MJ; Campos F; Marín T; Klein AD; Futerman AH; Alvarez AR; Zanlungo S
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166089. PubMed ID: 33549745
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.
Daykin EC; Ryan E; Sidransky E
Mol Genet Metab; 2021 Feb; 132(2):49-58. PubMed ID: 33483255
[TBL] [Abstract][Full Text] [Related]
7. Murine models of acute neuronopathic Gaucher disease.
Enquist IB; Lo Bianco C; Ooka A; Nilsson E; Månsson JE; Ehinger M; Richter J; Brady RO; Kirik D; Karlsson S
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17483-8. PubMed ID: 17954912
[TBL] [Abstract][Full Text] [Related]
8. An increase in ER stress and unfolded protein response in iPSCs-derived neuronal cells from neuronopathic Gaucher disease patients.
Pornsukjantra T; Saikachain N; Sutjarit N; Khongkrapan A; Tubsuwan A; Bhukhai K; Tim-Aroon T; Anurathapan U; Hongeng S; Asavapanumas N
Sci Rep; 2024 Apr; 14(1):9177. PubMed ID: 38649404
[TBL] [Abstract][Full Text] [Related]
9. Direct activation of microglia by β-glucosylceramide causes phagocytosis of neurons that exacerbates Gaucher disease.
Shimizu T; Schutt CR; Izumi Y; Tomiyasu N; Omahdi Z; Kano K; Takamatsu H; Aoki J; Bamba T; Kumanogoh A; Takao M; Yamasaki S
Immunity; 2023 Feb; 56(2):307-319.e8. PubMed ID: 36736320
[TBL] [Abstract][Full Text] [Related]
10. Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).
Nakanishi E; Uemura N; Akiyama H; Kinoshita M; Masanori S; Taruno Y; Yamakado H; Matsuzawa SI; Takeda S; Hirabayashi Y; Takahashi R
Mol Brain; 2021 May; 14(1):80. PubMed ID: 33971917
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapeutic targets for Gaucher disease.
Vitner EB; Vardi A; Cox TM; Futerman AH
Expert Opin Ther Targets; 2015 Mar; 19(3):321-34. PubMed ID: 25416676
[TBL] [Abstract][Full Text] [Related]
13. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH
Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206
[TBL] [Abstract][Full Text] [Related]
14. Brain pathology and cerebellar purkinje cell loss in a mouse model of chronic neuronopathic Gaucher disease.
Pewzner-Jung Y; Joseph T; Blumenreich S; Vardi A; Ferreira NS; Cho SM; Eilam R; Tsoory M; Biton IE; Brumfeld V; Haffner-Krausz R; Brenner O; Sharabi N; Addadi Y; Salame TM; Rotkopf R; Wigoda N; Yayon N; Merrill AH; Schiffmann R; Futerman AH
Prog Neurobiol; 2021 Feb; 197():101939. PubMed ID: 33152398
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration.
Davis MY; Trinh K; Thomas RE; Yu S; Germanos AA; Whitley BN; Sardi SP; Montine TJ; Pallanck LJ
PLoS Genet; 2016 Mar; 12(3):e1005944. PubMed ID: 27019408
[TBL] [Abstract][Full Text] [Related]
16. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
Sheth J; Bhavsar R; Mistri M; Pancholi D; Bavdekar A; Dalal A; Ranganath P; Girisha KM; Shukla A; Phadke S; Puri R; Panigrahi I; Kaur A; Muranjan M; Goyal M; Ramadevi R; Shah R; Nampoothiri S; Danda S; Datar C; Kapoor S; Bhatwadekar S; Sheth F
BMC Med Genet; 2019 Feb; 20(1):31. PubMed ID: 30764785
[TBL] [Abstract][Full Text] [Related]
17. Neurological effects of glucocerebrosidase gene mutations.
Mullin S; Hughes D; Mehta A; Schapira AHV
Eur J Neurol; 2019 Mar; 26(3):388-e29. PubMed ID: 30315684
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.
Furderer ML; Hertz E; Lopez GJ; Sidransky E
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628652
[TBL] [Abstract][Full Text] [Related]
19. PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects,
Zhao X; Lin Y; Liou B; Fu W; Jian J; Fannie V; Zhang W; Setchell KDR; Grabowski GA; Sun Y; Liu CJ
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2210442120. PubMed ID: 36574647
[TBL] [Abstract][Full Text] [Related]
20. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
